Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

Authors

Keywords

Journal

Volume 14, Issue 1, Pages 55-63

Publisher

Elsevier BV

Online

2012-11-20

DOI

10.1016/s1470-2045(12)70490-4

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now